Found: 14
Select item for more details and to access through your institution.
Tolerability of Rofecoxib versus Naproxen.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Gastrointestinal Tolerability and Effectiveness of Rofecoxib versus Naproxen in the Treatment of Osteoarthritis.
- Published in:
- Annals of Internal Medicine, 2003, v. 139, n. 7, p. 539
- By:
- Publication type:
- Article
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified by National Cholesterol Education Program Risk Category
- Published in:
- Metabolic Syndrome & Related Disorders, 2009, v. 7, n. 6, p. 601, doi. 10.1089/met.2009.0009
- By:
- Publication type:
- Article
Hypertension among osteoarthritis patients treated with rofecoxib, celecoxib, or acetaminophen: an analysis of the data from the pooled VACT studies
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Effect of rofecoxib vs. naproxen on hypertension and edema related events: a multivariate analysis involving 5557 patients from the advantage trial
- Published in:
- 2002
- By:
- Publication type:
- Abstract
Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Efficacy of Rofecoxib, Celecoxib, and Acetaminophen in Osteoarthritis of the Knee.
- Published in:
- JAMA: Journal of the American Medical Association, 2002, v. 287, n. 1, p. 64, doi. 10.1001/jama.287.1.64
- By:
- Publication type:
- Article
Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial.
- Published in:
- Journal of the American Geriatrics Society, 2004, v. 52, n. 5, p. 666, doi. 10.1111/j.1532-5415.2004.52201.x
- By:
- Publication type:
- Article
Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 148, p. 1, doi. 10.1126/scitranslmed.3003877
- By:
- Publication type:
- Article
Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.
- Published in:
- International Wound Journal, 2007, v. 4, n. 1, p. 30, doi. 10.1111/j.1742-481X.2006.00274.x
- By:
- Publication type:
- Article
A reply to Dr Steiner.
- Published in:
- Cephalalgia, 1998, v. 18, n. 4, p. 227, doi. 10.1046/j.1468-2982.1998.1804227-2.x
- By:
- Publication type:
- Article
The value of a wound score for diabetic foot infections in predicting treatment outcome: A prospective analysis from the SIDESTEP trial.
- Published in:
- Wound Repair & Regeneration, 2009, v. 17, n. 5, p. 671, doi. 10.1111/j.1524-475X.2009.00521.x
- By:
- Publication type:
- Article
Fixed-dose combination ezetimibe+atorvastatin lowers LDL-C equivalent to co-administered components in randomized trials: use of a dose-response model.
- Published in:
- Fundamental & Clinical Pharmacology, 2015, v. 29, n. 2, p. 209, doi. 10.1111/fcp.12096
- By:
- Publication type:
- Article